Reinforcing transplantation with consolidation therapy in Hodgkin lymphoma
Overview of a Phase II clinical trial of isatuximab
Treatment at first relapse in multiple myeloma: how to choose a drug?
Why we need novel strategies for diffuse large B-cell lymphoma
Phase III ASPIRE study and prospective anti-CD38 therapy for myeloma